Results 41 to 50 of about 5,643,282 (147)

Imaging Advances in Heart Failure

open access: yesCardiac Failure Review
This paper delves into the significance of imaging in the diagnosis, aetiology and therapeutic guidance of heart failure, aiming to facilitate early referral and improve patient outcomes. Imaging plays a crucial role not only in assessing left ventricular ejection fraction, but also in characterising the underlying cardiac abnormalities and reaching a ...
Ritu Thamman   +6 more
openaire   +3 more sources

Algorithm for Treatment of Advanced Heart Failure

open access: yes, 2013
Heart failure is a growing epidemic worldwide that confers a substantial medical and economic burden on our society. With the aging population and the improved treatment strategies made available over the last several decades including neurohormonal ...
Allareddy, Mrudula R.   +12 more
core   +1 more source

22 Supportive cardiology: an innovative practice model to integrate palliative care into the management of advanced heart failure

open access: yes, 2018
Despite advances in evidence-based treatment to improve survivorship of patients with heart failure, the progressive deteriorating disease trajectory results in an expanding cohort of patients with advanced disease stage.
Woo, Jean   +24 more
core   +1 more source

Renal Response to Levosimendan in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation Predicts Early Postoperative Renal Function Course

open access: yesJournal of Cardiovascular Development and Disease
Background: Beyond its established inotropic effects, levosimendan has been reported to enhance renal function in patients with chronic heart failure. In this study, we investigated whether changes in renal function following levosimendan administration ...
Gregor Zemljic   +7 more
doaj   +1 more source

A Holistic View of Advanced Heart Failure

open access: yesLife, 2022
Advanced heart failure (HF) may occur at any level of left ventricular (LV) ejection fraction (LVEF). The latter, which is widely utilized for the evaluation of LV systolic performance and treatment guidance of HF patients, is heavily influenced by LV size and geometry.
Filippos Triposkiadis   +5 more
openaire   +3 more sources

Impella 5.5 as a bridge-to-surgery in acute ischemic mitral regurgitation post-percutaneous coronary intervention: a case report

open access: yesJournal of Cardiothoracic Surgery
Background Acute ischemic mitral regurgitation (AIMR) is a significant complication of acute coronary syndrome that leads to severe and immediate hemodynamic deterioration and cardiogenic shock.
Ioana Dumitru   +6 more
doaj   +1 more source

Case report: decommissioning of a left ventricular assist device following reverse remodeling in non-ischemic cardiomyopathy patient

open access: yesJournal of Cardiothoracic Surgery
Background Left ventricular assist devices (LVAD) improves clinical outcomes in patients with advanced heart failure (HF) and may induce myocardial recovery.
Sabina Ugovšek   +8 more
doaj   +1 more source

Management of Tacrolimus-induced thrombotic microangiopathy in a heart transplant recipient: Utilizing novel immunosuppression strategies

open access: yesJHLT Open
Thrombotic microangiopathy (TMA) represents a heterogeneous group of disorders characterized by endothelial injury, complement activation, and platelet aggregation, and may occur in association with systemic diseases, infections, or drug exposure.
Petra Girandon Sušanj, MD   +8 more
doaj   +1 more source

Accuracy of 3-Dimensional Transoesophageal Echocardiography in Assessment of Prosthetic Mitral Valve Dehiscence with Comparison to Anatomical Specimens

open access: yesCardiology Research and Practice, 2010
The evolution of echocardiography from 2-Dimensional Transthoracic Echo through to real time 3-Dimensional Transoesophageal Echo has enabled more accurate visualisation and quantification of valvular disorders especially prosthetic mitral valve ...
Martin R. Brown   +2 more
doaj   +1 more source

Recent advances in treatment of heart failure [PDF]

open access: yesF1000Research, 2015
With the total cases and economic burden of heart failure continuing to rise, there is an overwhelming need for novel therapies. Several drugs for heart failure have succeeded in preclinical and early-phase clinical trials, but most of them failed to show the real benefit in pivotal clinical trials.
Takeshi Kitai, WH Wilson Tang
openaire   +2 more sources

Home - About - Disclaimer - Privacy